Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508C and YHR2603 in healthy subjects
Epistemonikos ID: 1c31df1895d40770beede2cd72fb45ebe4c072ec
First added on: May 14, 2026